14-75003028-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014239.4(EIF2B2):āc.38A>Gā(p.Glu13Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,613,976 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_014239.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152140Hom.: 1 Cov.: 31
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251280Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135894
GnomAD4 exome AF: 0.0000150 AC: 22AN: 1461836Hom.: 0 Cov.: 33 AF XY: 0.0000234 AC XY: 17AN XY: 727228
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152140Hom.: 1 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74324
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.38A>G (p.E13G) alteration is located in exon 1 (coding exon 1) of the EIF2B2 gene. This alteration results from a A to G substitution at nucleotide position 38, causing the glutamic acid (E) at amino acid position 13 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at